MIF interacts with CXCR7 to promote receptor internalization, ERK1/2 and ZAP-70 signaling, and lymphocyte chemotaxis, FASEB J, vol.29, pp.4497-4511, 2015. ,
Analysis of macrophage migration inhibitory factor (MIF) in patients with idiopathic pulmonary fibrosis, Respir Physiol Neurobiol, vol.167, pp.261-267, 2009. ,
MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment, Nat Med, vol.13, pp.587-596, 2007. ,
Optimising experimental research in respiratory diseases: an ERS statement, Eur Respir J, vol.51, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01996906
Neutralization of CXCL12 attenuates established pulmonary hypertension in rats, Cardiovasc Res, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02366304
An MIF Promoter Polymorphism Is Associated with Susceptibility to Pulmonary Arterial Hypertension in Diffuse Cutaneous Systemic Sclerosis, J Rheumatol, vol.44, pp.1453-1457, 2017. ,
Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension, Eur Respir J, vol.50, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01757586
Attenuation of leukocyte recruitment via CXCR1/2 inhibition stops the progression of PAH in mice with genetic ablation of endothelial BMPR-II, Blood, vol.118, pp.4750-4758, 2011. ,
Genetic variation in the mitochondrial enzyme carbamyl-phosphate synthetase I predisposes children to increased pulmonary artery pressure following surgical repair of congenital heart defects: a validated genetic association study, Mitochondrion, vol.7, pp.204-210, 2007. ,
A role for the CXCL12 receptor, CXCR7, in the pathogenesis of human pulmonary vascular disease, Eur Respir J, vol.39, pp.1415-1424, 2012. ,
The unmet medical need of pulmonary hypertension in idiopathic pulmonary fibrosis, Eur Respir J, vol.51, 2018. ,
Endothelial and Smooth Muscle Cell Interaction via FoxM1 Signaling Mediates Vascular Remodeling and Pulmonary Hypertension, American journal of respiratory and critical care medicine, vol.198, pp.788-802, 2018. ,
Macrophage migration inhibitory factor (MIF) promotes fibroblast migration in scratch-wounded monolayers in vitro, FEBS Lett, vol.581, pp.4734-4742, 2007. ,
Macrophage migration inhibitory factor as a novel biomarker of portopulmonary hypertension, Pulm Circ, vol.6, pp.498-507, 2016. ,
Pulmonary arterial hypertension in adults born with a heart septal defect: the Euro Heart Survey on adult congenital heart disease, Heart, vol.93, pp.682-687, 2007. ,
CXCR4 inhibition ameliorates severe obliterative pulmonary hypertension and accumulation of C-kit(+) cells in rats, PLoS One, vol.9, p.89810, 2014. ,
ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the, ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT), vol.46, pp.903-975, 2015. ,
Targeting of c-kit+ haematopoietic progenitor cells prevents hypoxic pulmonary hypertension, Eur Respir J, vol.37, pp.1392-1399, 2011. ,
Pulmonary arterial hypertension associated with congenital heart disease: recent advances and future directions, Int J Cardiol, vol.177, pp.340-347, 2014. ,
MIF and CD74 -suitability as clinical biomarkers, Mini Rev Med Chem, vol.14, pp.1125-1131, 2014. ,
Pathology and Pathobiology of Pulmonary Hypertension. Seminars in respiratory and critical care medicine, vol.38, pp.571-584, 2017. ,
New molecular targets of pulmonary vascular remodeling in pulmonary arterial hypertension: importance of endothelial communication, Chest, vol.147, pp.529-537, 2015. ,
Macrophage Migration Inhibitory Factor (MIF) Inhibition in a Murine Model of Bleomycin-Induced Pulmonary Fibrosis, Int J Mol Sci, vol.19, 2018. ,
URL : https://hal.archives-ouvertes.fr/inserm-02612651
Role of MIF and D-DT in immune-inflammatory, autoimmune, and chronic respiratory diseases: from pathogenic factors to therapeutic targets, Drug Discov Today, 2018. ,
Role of MIF and D-DT in immune-inflammatory, autoimmune, and chronic respiratory diseases: from pathogenic factors to therapeutic targets, Drug discovery today, vol.24, pp.428-439, 2019. ,
Macrophage migration inhibitory factor-knockout mice are long lived and respond to caloric restriction, FASEB J, vol.24, pp.2436-2442, 2010. ,
Pulmonary hypertension in heart failure with preserved ejection fraction: a plea for proper phenotyping and further research, European heart journal, vol.38, pp.2869-2873, 2017. ,
Deficiency of the macrophage migration inhibitory factor gene has no significant effect on endotoxaemia, Immunology, vol.100, pp.84-90, 2000. ,
Pulmonary vascular endothelium: the orchestra conductor in respiratory diseases: Highlights from basic research to therapy, The European respiratory journal, vol.51, 2018. ,
Immune dysregulation and endothelial dysfunction in pulmonary arterial hypertension: a complex interplay, Circulation, vol.129, pp.1332-1340, 2014. ,
New targets for pulmonary arterial hypertension: going beyond the currently targeted three pathways, Curr Opin Pulm Med, vol.23, pp.377-385, 2017. ,
Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives, Eur Respir J, vol.53, 2019. ,
Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension, American journal of respiratory and critical care medicine, vol.151, pp.1628-1631, 1995. ,
Serum macrophage migration inhibitory factor levels are correlated with response to tocilizumab therapy in patients with rheumatoid arthritis, Rheumatol Int, vol.34, pp.429-433, 2014. ,
Serum Macrophage Migration Inhibitory Factor (MIF) Is Increased In Patients With Pulmonary Arterial Hypertension, American journal of respiratory and critical care medicine, vol.183, p.1990, 2011. ,
Macrophage Migration Inhibitory Factor (MIF)-Deficient Mice Are Protected From Right Ventricular Remodeling In A Model Of Chronic Hypoxia-Induced Pulmonary Hypertension, American journal of respiratory and critical care medicine, vol.183, p.4971, 2011. ,
Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study, Journal of the American College of Cardiology, vol.53, pp.1119-1126, 2009. ,
Synthesis, and Biological Activity of New N-(Phenylmethyl)-benzoxazol-2-thiones as Macrophage Migration Inhibitory Factor (MIF) Antagonists: Efficacies in Experimental Pulmonary Hypertension, J Med Chem, vol.61, pp.2725-2736, 2018. ,
URL : https://hal.archives-ouvertes.fr/inserm-02580381
Proinflammatory Signature of the Dysfunctional Endothelium in Pulmonary Hypertension. Role of the Macrophage Migration Inhibitory Factor/CD74 Complex, American journal of respiratory and critical care medicine, vol.192, pp.983-997, 2015. ,
URL : https://hal.archives-ouvertes.fr/inserm-02579320
Emergence of fibroblasts with a proinflammatory epigenetically altered phenotype in severe hypoxic pulmonary hypertension, J Immunol, vol.187, pp.2711-2722, 2011. ,
Circulating macrophage migration inhibitory factor (MIF) in patients with heart failure, Cytokine, vol.110, pp.104-109, 2018. ,
Predictive potential of macrophage migration inhibitory factor (MIF) in patients with heart failure with preserved ejection fraction (HFpEF), Eur J Med Res, vol.23, p.22, 2018. ,
Relation of Macrophage Migration Inhibitory Factor to Pulmonary Hemodynamics and Vascular Structure and Carbamyl-Phosphate Synthetase I Genetic Variations in Pediatric Patients with Congenital Cardiac Shunts, Mediators Inflamm, p.7305028, 2019. ,
Complexity of macrophage migration inhibitory factor (MIF) and other angiogenic biomarkers profiling in pulmonary arterial hypertension, Pulm Circ, vol.7, pp.730-733, 2017. ,
C-kit-positive cells accumulate in remodeled vessels of idiopathic pulmonary arterial hypertension, Am J Respir Crit Care Med, vol.184, pp.116-123, 2011. ,
Genetics and genomics of pulmonary arterial hypertension, The European respiratory journal, vol.53, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02137830
MIF inhibition enhances pulmonary angiogenesis and lung development in congenital diaphragmatic hernia, Pediatric research, vol.85, pp.711-718, 2019. ,
Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension, Circ Res, vol.115, pp.165-175, 2014. ,
Macrophage Migration Inhibitory Factor-CXCR4 Receptor Interactions: EVIDENCE FOR PARTIAL ALLOSTERIC AGONISM IN COMPARISON WITH CXCL12 CHEMOKINE, J Biol Chem, vol.291, pp.15881-15895, 2016. ,
High expression levels of macrophage migration inhibitory factor sustain the innate immune responses of neonates, Proc Natl Acad Sci U S A, vol.113, pp.997-1005, 2016. ,
The MIF Antagonist ISO-1 Attenuates Corticosteroid-Insensitive Inflammation and Airways Hyperresponsiveness in an Ozone-Induced Model of COPD, PLoS One, vol.11, p.146102, 2016. ,
Antagonism of CXCR7 attenuates chronic hypoxia-induced pulmonary hypertension, Pediatr Res, vol.71, pp.682-688, 2012. ,
Haemodynamic definitions and updated clinical classification of pulmonary hypertension, Eur Respir J, vol.53, 2019. ,
Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension, Circulation, vol.122, pp.920-927, 2010. ,
Elevated serum levels of macrophage migration inhibitory factor and stem cell growth factor beta in patients with idiopathic and systemic sclerosis associated pulmonary arterial hypertension, Reumatismo, vol.66, pp.270-276, 2015. ,
Characterization of genomic structure and polymorphisms in the human carbamyl phosphate synthetase I gene, Gene, vol.311, pp.51-57, 2003. ,
Discovery of Distinct Immune Phenotypes Using Machine Learning in Pulmonary Arterial Hypertension, Circulation research, vol.124, pp.904-919, 2019. ,
Ectopic upregulation of membrane-bound IL6R drives vascular remodeling in pulmonary arterial hypertension, The Journal of clinical investigation, vol.128, pp.1956-1970, 2018. ,
URL : https://hal.archives-ouvertes.fr/inserm-02580448
MIF family cytokines in cardiovascular diseases and prospects for precision-based therapeutics, Expert Opin Ther Targets, vol.21, pp.671-683, 2017. ,
Contemporary prevalence of pulmonary arterial hypertension in adult congenital heart disease following the updated clinical classification, Int J Cardiol, vol.174, pp.299-305, 2014. ,
Pathobiology of pulmonary arterial hypertension and right ventricular failure, The European respiratory journal, vol.40, pp.1555-1565, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-02612634
Pro-inflammatory action of MIF in acute myocardial infarction via activation of peripheral blood mononuclear cells, PLoS One, vol.8, p.76206, 2013. ,
Macrophage migration inhibitory factor contributes to hypoxic pulmonary vasoconstriction in rats, Microvasc Res, vol.83, pp.205-212, 2012. ,
Role of macrophage migration inhibitory factor in the proliferation of smooth muscle cell in pulmonary hypertension, Mediators Inflamm, p.840737, 2012. ,
High expression of CXCR4 and stem cell markers in a monocrotaline and chronic hypoxia-induced rat model of pulmonary arterial hypertension, Exp Ther Med, vol.15, pp.4615-4622, 2018. ,
Macrophage migration inhibitory factor mediates hypoxia-induced pulmonary hypertension, Mol Med, vol.18, pp.215-223, 2012. ,
Serum Cytokines in Young Pediatric Patients with Congenital Cardiac Shunts and Altered Pulmonary Hemodynamics, Mediators Inflamm, p.7672048, 2016. ,